On behalf of the Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) and the Australasian Association for Clinical Biochemistry and Laboratory Medicine (AACB), we invite you to attend the Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) Congress 2024 which will be held at the International Convention Centre Sydney, Australia from 31 October – 3 November 2024.
The Asia Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB) was formally established in 1982 with originally just 5 member societies. Today in 2023, after more than forty years of growth and development, the APFCB is a massive regional federation whose member countries contain approximately half the world’s population; currently there are 18 Full Members, 5 Affiliate Members and 22 Corporate Members.
Apart from the size, a feature of the APFCB is the diverse range of laboratory practices. As a Federation committed to raising the quality, equity and sustainability of Laboratory Medicine region throughout our region, this enables a unique position for drawing on the expertise of the more developed societies to assist the less developed.
The APFCB also has a good history of collaboration with other international federations, particularly a long-standing partnership and vital support from the IFCC. In addition, the APFCB has on-going MoUs with the World Association of Societies of Pathology and Laboratory Medicine (WASPaLM) and the American Association for Clinical Chemistry (AACC).
The Australasian Association for Clinical Biochemistry and Laboratory Medicine (AACB) is the principal professional association dedicated to the advancement of Clinical Biochemistry and Laboratory Medicine in Australasia. Their role is to provide education, training and other professional development opportunities for our members - pathologists, medical scientists and technicians working in pathology laboratories in the Australasian region.
The AACB is a full member of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and Asia-Pacific Federation for Clinical Biochemistry and Laboratory Medicine (APFCB). Membership of the Association provides both professional and individual benefits. Members of AACB are kept informed of the latest news, views and developments in clinical biochemistry, and kept up to date with the latest developments in science, education and related political issues.
Domestically, the Association has a close relationship with the Royal College of Pathologists of Australasia (RCPA) where we have around 100 members common to both societies. Similarly, we have close ties with the Australian Institute of Medical Scientists (AIMS) with approximately 95 members of this group also members of the AACB. We also have a strong working relationship with the RCPA Chemical Pathology QAP.
The AACB actively participates in the Pathology Associations Council.
Internationally, we meet regularly with the Association for Clinical Biochemistry (ACB) and the American Association for Clinical Chemistry (AACC). We have formal agreements of cooperation with both organisations.
